期刊文献+

HPLC法测定组织中雷帕霉素的含量 被引量:6

Determination of Rapamycin in tissues of rabbit by HPLC
下载PDF
导出
摘要 目的建立测定雷帕霉素在组织中含量的高效液相色谱方法。方法采用AlltechC18柱,以乙腈∶四氢呋喃∶(55∶40)为流动相,检测波长为278nm。结果线性回归方程为A=3.2481C+7.4082×10-水5∶3,r=0.9925。在4~128ng/ml范围内线性良好。结论本法操作简单,重现性好,可用于测定组织中雷帕霉素的含量。 Objective To establish a HPLC method for content determination of rapamycin in tissues. Method Alhech C18 column was used. The mobile phase was the mixture (acetonitrile:tetrahydro-furan: waler =55 :5 :40). The deteclion wavelength was 278nm. Results Calibration curves was A=3,2481C+ 7.4082×10^-3, r=0.9925. A good linearity was shown over the concentration range of 4-128ng/ml. Conclusion The method is simple and reproducible. It is suilable for content determination of rapamyein in tissues.
出处 《实用医药杂志》 2008年第7期813-814,共2页 Practical Journal of Medicine & Pharmacy
基金 南通市科委资助项目(项目号:s30037)
关键词 雷帕霉素 高效液相色谱法 组织药物含量 Rapamycin HPLC Drug content in tissues
  • 相关文献

参考文献4

  • 1Morice CM, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med, 2002,346:1773.
  • 2Manuel Pan, Jose Suarez de Lezo, Alfonso Medina, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. American Heart Journal, 2004,148(5):857.
  • 3Thomas Schachner, Yping Zou, Alexander Oberhuber, et al. Local application of Rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg, 2004,77:1580.
  • 4David WH, Terry L, Kimty J, et al. Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. Clin Chem. 2000,46(8):1179.

同被引文献40

  • 1李冠军,董桂青,金仲品.西罗莫司的研究进展[J].中国医疗前沿(学术版),2008,3(1):34-36. 被引量:4
  • 2余国膺.西罗莫司对循环中的血管祖细胞具有强大抑制作用[J].中国介入心脏病学杂志,2005,13(2):107-107. 被引量:1
  • 3杨岷,陈长志,成少飞,王学宁,叶清,王维俊,王小妹.牛心包组织工程心脏瓣膜支架脱细胞方法的比较[J].中华胸心血管外科杂志,2005,21(6):349-351. 被引量:16
  • 4王学宁,陈长志,杨岷,吴学军,张谷兰.肝素处理小口径脱细胞异种血管的移植研究[J].中华胸心血管外科杂志,2006,22(5):324-325. 被引量:4
  • 5Huang S, Houghton PJ, Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curt Opin Investig Drugs ,2002,3:295.
  • 6Neshat MS, Mellinghoff IK, Tran C, et al. Enhanced sensitivity of PTEN - deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci USA ,2001,98 : 10314.
  • 7Yu K,Toral -Barza L, Discafani C, et al. mTOR, a novel target in breast cancer:the effect of CCI-779 ,an mTOR inhibitor,in preclinical models of breast cancer. Endocr Relat Cancer,2001,8:249.
  • 8G Rajender, Narayanan NGB. Liquid Chromatography- tandem mass spectrometry method for determination of Sirolimus coated drug eluting nano porous carbon stents. Biomedical Chromatography. www. interscience .wiley. com/journal/bmc ,2009 - 5 - 21/2009 - 10 - 14.
  • 9STOJKOVIC S, OSTOJIC M, NEDELJKOVIC M, et al Sys- temic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation[J]. Catheter Cardio- vasc Interv, 2010, 75(3): 317-325.
  • 10MOSES JW, LEON MB, POPMA JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl J Med, 2003, 349(14): 1315-1323.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部